SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

gi-specialist

Barrett's Esophagus: What It Is, Symptoms, and Cancer Risk

Barrett's esophagus is a change in the lining of the lower esophagus caused by long-term exposure to stomach acid. It can develop in people with chronic GERD and raises the risk of a specific type of esophageal cancer. Regular endoscopic surveillance managed by a gastroenterologist is the cornerstone of care.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

What is Barrett's esophagus?

Normally, the esophagus is lined with a pale, flat (squamous) type of tissue. In Barrett's esophagus, repeated acid exposure causes that lining to be replaced by a reddish, column-shaped (intestinal-type) tissue — a process called intestinal metaplasia. This change is visible during upper endoscopy and can be confirmed by biopsy 1.

Barrett's esophagus itself does not cause pain or symptoms distinct from GERD. Most people learn they have it during an endoscopy done for other reasons — typically long-standing heartburn.

What causes Barrett's esophagus?

Chronic gastroesophageal reflux disease (GERD) is the primary risk factor. When acid repeatedly reaches the esophagus over years, the lining adapts to protect itself — but the adapted tissue carries its own risk 12.

Other factors associated with a higher likelihood of developing Barrett's include: - Long duration of GERD symptoms (more than five years) - Male sex - Obesity, particularly central (abdominal) obesity - Older age - Smoking history

Not every person with GERD develops Barrett's, and some people with Barrett's have few or no reflux symptoms.

What is the cancer risk?

Barrett's esophagus can progress through stages of cell change — from no dysplasia, to low-grade dysplasia, to high-grade dysplasia, to esophageal adenocarcinoma. The overall annual risk of progression to cancer in people with Barrett's without dysplasia is quite low (approximately 0.1–0.3% per year). However, that risk rises significantly with high-grade dysplasia 13.

This progression is why surveillance matters: catching and treating dysplasia before cancer develops is the goal of regular endoscopy.

It is important not to overstate the individual risk. The majority of people with Barrett's esophagus do not develop esophageal cancer during their lifetime. Surveillance allows clinicians to monitor for changes and act early if needed.

How is Barrett's esophagus diagnosed?

Diagnosis requires upper endoscopy (EGD — esophagogastroduodenoscopy). During this outpatient procedure, a gastroenterologist passes a thin flexible camera through the mouth to view the esophageal lining directly. Biopsies (small tissue samples) are taken to confirm intestinal metaplasia and to assess whether dysplasia (pre-cancerous cell changes) is present.

Blood tests and imaging do not diagnose Barrett's. Endoscopy is the necessary step 13.

Screening endoscopy for Barrett's is generally considered for people with chronic GERD plus multiple risk factors (male sex, age over 50, obesity, smoking, or a family history of Barrett's or esophageal adenocarcinoma) 3.

What does surveillance and monitoring look like?

Surveillance frequency depends on whether dysplasia is present 3:

  • No dysplasia: Repeat endoscopy every three to five years
  • Low-grade dysplasia: More frequent surveillance (every six to twelve months) or intervention, discussed with the gastroenterologist
  • High-grade dysplasia: Intervention is recommended, typically endoscopic eradication therapy rather than surgery in most cases

Endoscopic eradication techniques include radiofrequency ablation (RFA), which uses heat to destroy the abnormal lining, and endoscopic mucosal resection (EMR) for visible nodules. These have replaced surgical approaches for most high-grade dysplasia 2.

Staying on acid-suppression therapy (proton pump inhibitors) is generally recommended to reduce ongoing acid damage, though it does not reverse Barrett's that has already developed.

Can Barrett's esophagus be treated or reversed?

Lifestyle measures that reduce GERD — raising the head of the bed, avoiding large late meals, limiting alcohol and tobacco, maintaining a healthy weight — reduce acid exposure and may slow progression, but do not reliably reverse the existing Barrett's lining.

Endoscopic eradication therapy (radiofrequency ablation) can successfully remove the Barrett's lining in most patients and allows the normal squamous lining to regrow, particularly when dysplasia is present 2.

For people with no dysplasia, observation with surveillance is the standard approach. Intervening on all Barrett's without dysplasia is not currently supported by major guidelines given the low annual cancer risk and the small risks of any procedure 3.

Why does a gastroenterologist manage this condition?

Barrett's esophagus requires endoscopic expertise — for accurate diagnosis, high-quality biopsy sampling, and the ability to perform endoscopic treatments if needed. A gastroenterologist specializing in Barrett's will coordinate your surveillance schedule and determine if and when intervention is appropriate.

If you have chronic GERD (symptoms most days, lasting more than five years), or GERD that does not fully respond to medication, speaking with a gastroenterologist is a reasonable next step. Gale can help you prepare for that conversation, understand your options, and find a specialist.

Common questions

If I have Barrett's esophagus, will I get cancer?

Most people with Barrett's esophagus do not develop esophageal cancer during their lifetime. The annual progression risk for those without dysplasia is quite low. Regular surveillance allows clinicians to detect and treat any cell changes before cancer develops.

Does Barrett's esophagus cause symptoms?

Barrett's itself does not produce symptoms distinct from GERD. Many people with Barrett's experience heartburn, regurgitation, or both — but these are caused by the underlying acid reflux, not the Barrett's change in the lining.

Do I need surgery if I have Barrett's esophagus?

Surgery is rarely needed. Most people with Barrett's — even those with dysplasia — can be managed with endoscopic treatments and surveillance. High-grade dysplasia is now typically treated with endoscopic ablation rather than esophageal surgery.

How often will I need endoscopy?

It depends on what the biopsy shows. Without dysplasia, guidelines suggest surveillance every three to five years. With dysplasia, more frequent monitoring or treatment is recommended. Your gastroenterologist will give you a specific schedule based on your biopsy results.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

Symptoms that need prompt evaluation

  • —Difficulty or pain with swallowing (dysphagia) — can signal narrowing or a mass in the esophagus
  • —Unexplained weight loss combined with GERD symptoms
  • —Vomiting blood or passing black, tarry stools
  • —GERD symptoms that do not improve with medication after several weeks

Vomiting blood or passing black tarry stools requires immediate emergency care — call 911 or go to the nearest emergency room.

This article is for general education only. It does not replace evaluation by a gastroenterologist. Only an endoscopy with biopsy can diagnose Barrett's esophagus or assess dysplasia. Gale can help you find a gastroenterologist and prepare for your visit.

References

  1. 1.Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ (2022). ACG Clinical Guideline: Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology. doi:10.14309/ajg.0000000000001538 ✓Risk factors for Barrett's esophagus, GERD as the primary driver, and management approach
  2. 2.Yadlapati R, Gyawali CP, Pandolfino JE; CGIT GERD Consensus Conference Participants (2022). AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2022.01.025 ✓GERD complications including Barrett's, endoscopic evaluation, and endoscopic eradication therapy including radiofrequency ablation
  3. 3.Shaheen NJ, Falk GW, Iyer PG, Souza RF, Yadlapati RH, Sauer BG, Wani S (2022). Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. American Journal of Gastroenterology. doi:10.14309/ajg.0000000000001680 ✓Dysplasia grading, cancer risk quantification (~0.1-0.3% annual progression without dysplasia), surveillance intervals, screening criteria, and endoscopic eradication recommendations

3 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.